December 2011
SARomics Biostructures has determined an additional crystal structure of the carbohydrate recognition domain of galectin-3 in complex with a designed ligand. The ligand was developed by a research group headed by Professor Ulf Nilsson and Professor Hakon Leffler at the Depts. of Organic Chemistry and Division of Microbiology, Immunology and Glycobiology at Lund University, respectively. Prof. Nilsson and Prof. Leffler have recently co-funded the company Galecto Biotech which focuses on developing novel drugs targeting galectins for the treatment of fibrosis, inflammation and other serious human diseases.